openPR Logo
Press release

Acute Heart Failure (AHF) Therapeutics Market: Drivers, Regional Analysis, and Competitive Landscape 2026

07-11-2018 04:23 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Acute Heart Failure (AHF) Therapeutics Market: Drivers,

Acute heart failure (AHF) is a progressive condition, in which, the heart muscle is unable to pump enough blood through the heart to meet body’ optimal blood and oxygen level. Congestive heart failure is type of heart failure which requires timely medical attention. Moreover, distinguish between acute and chronic heart failure is important from a clinical standpoint, on which further medication depends. For this, N terminal proB-type natriuretic peptide levels are used for distinguishing acute versus chronic left ventricular dysfunction. An elevated levels of natriuretic peptide were present in patients with acute heart failure compared to those with chronic heart failure patient.

Get PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-pdf/1910

Heart failure symptoms vary widely from person to person, depending on types of heart failure patient. The main symptoms of heart failure are caused due to fluid accumulation or congestion and poor blood flow to the body. Symptoms caused by fluid accumulation or congestion includes shortness of breath, weight gain, coughing, swollen ankles, legs or abdomen, while dizziness, rapid heart rate, and fatigue are symptoms associated with reduced blood flow to parts of the body.

Acute Heart Failure (AHF) Therapeutics Market Drivers

The global acute heart failure therapeutics market is expected to witness significant growth due to approval of new drugs. For instance, in July 2015, Novartis received U.S. Food and Drug Administration (FDA) approval for their Entresto(TM) (sacubitril/valsartan) tablets on the treatment of heart failure with reduced ejection fraction. Entresto is indicated to reduce the risk of cardiovascular death and heart failure hospitalization.

Click to Continue Reading on Acute Heart Failure (AHF) Therapeutics Market: https://www.coherentmarketinsights.com/ongoing-insight/acute-heart-failure-ahf-therapeutics-market-1910

Furthermore, robust pipeline of drugs over the forecast period (2018-2026), is another factor driving growth of acute heart failure therapeutics market. For instance, in March 2017, Cardioxyl Pharmaceuticals’ CXL-1427: a novel nitroxyl (HNO) donor (prodrug), which now operates under the Bristol-Myers Squibb Company (after Cardioxyl Pharmaceuticals’ acquisition by Bristol-Myers Squibb in December 2015); is present in Phase 2 clinical development phase. CXL-1427 is indicated to use as an intravenous treatment for acute decompensated heart failure (ADHF). Successful completion and further launch of Bristol-Myers Squibb’s innovative drug in future, will help to boost the acute heart failure (AHF) therapeutics market growth during the forecast period.

Various lifestyle factors are responsible to increase risk heart attack and stroke, which includes smoking, overweight, eating foods with high fat and cholesterol, and physical inactivity. Furthermore, patients suffering with heart failure are at high risk to one or more conditions such as coronary artery disease, myocardial infraction, high blood pressure or hypertension, abnormal heart valves, dilated cardiomyopathy, hypertrophic cardiomyopathy, severe lung disease, obesity, and sleep apnea, among others. For instance, according to the World Health Organization (WHO), October 2017 data findings, in 2016, over 1.9 billion adults, were overweight, worldwide. Among which over 650 million were obese. Moreover, according to the same source, raised BMI index, owing to overweight and obesity are the major risk factors for cardiovascular disease, which was the leading cause of death in 2012, worldwide.

Request Sample: https://www.coherentmarketinsights.com/insight/request-sample/1910

Acute Heart Failure (AHF) Therapeutics Market Restraints

Acute heart failure is a common condition associated with considerable morbidity, mortality, and cost. However, evidence-based data on treating heart failure in the acute setting are limited, and current individual treatment options have variable efficacy. Furthermore, healthcare team often need to customize patient care in acute heart failure treatment. For instance, dyspnea is the most common symptom associated with AHF patients. However, this symptom is non-specific as other medical conditions are commonly associated with dyspnea, including pneumonia, exacerbations of chronic obstructive pulmonary disease, pulmonary embolism, acute coronary syndrome, and asthma. This is another factor negatively affecting growth of the acute heart failure (AHF) therapeutics market.

Acute Heart Failure (AHF) Therapeutics Market – Regional Analysis

Geographically, the market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America is expected to hold dominant position in global acute heart failure (AHF) therapeutics market, due to high prevalence of acute heart failure cases, in this region. For instance, according to Centers for Disease Control and Prevention (CDC), June 2016, around 5.7 million adults in the U.S. suffered from heart failure, in 2016. Moreover, about half of the people who develop heart failure die within 5 years of diagnosis.

Furthermore, growing prevalence of obesity have increased risk of developing acute heart failure (AHF). According to CDC, May 2017 data findings, between 2013 and 2014, 37.9% of adults aged 20 years and over were obese, in the U.S. Therefore, high prevalence of risk factors and acute heart failure (AHF) cases in these region are expected to drive growth of this market over the forecast period.

Asia Pacific acute heart failure (AHF) therapeutics market is projected to witness significant growth, due to increasing focus of healthcare organizations in creating awareness regarding increasing risk factors of acute heart failure. For instance, in June 2016, Fortis Hospital, India launched Fortis Heart Rhythm and Heart failure Centre in Bangalore, to increase awareness among people regarding heart failure, stroke, and various other cardiovascular disease.

Request Discount: https://www.coherentmarketinsights.com/insight/request-discount/1910

Acute Heart Failure (AHF) Therapeutics Market – Competitive Landscape

Some of the key players in this market are Novartis AG, Cardiorentis AG, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Cytokinetics, Inc., Merck & Company, Inc., Ono Pharmaceutical Co., Ltd., and Pfizer Inc., among others. Key players in the marker are engaged in development of new drugs for acute heart failure (AHF). These players are incorporating collaboration strategies to remain competitive in the market.

For instance, in October 2015, Cardiorentis AG announced plans to collaborate with Roche to establish therapeutic efficacy and safety of Ularitide: Cardiorentis’ investigational drug for acute heart failure (AHF). Under the terms of collaboration, Cardiorentis will incorporate Roche's advanced in vitro diagnostic tests into its TRUE-AHF Phase III study to characterize the pharmacological properties of Ularitide, evaluate its benefit-risk profile, and the appropriate clinical application in patients.

Acute Heart Failure (AHF) Therapeutics Market Taxonomy

By Disorder Type

Right-sided Heart Failure
Left-sided Heart Failure
Systolic Failure
Diastolic Failure
Congestive Heart Failure

By Drug Category

Angiotensin-Converting Enzyme (ACE) Inhibitors
Captopril (Capoten)
Enalapril (Vasotec)
Fosinopril (Monopril)
Lisinopril (Prinivil, Zestril)
Perindopril (Aceon)
Quinapril (Accupril)
Ramipril (Altace)
Others

Angiotensin II Receptor Blockers
Candesartan (Atacand)
Losartan (Cozaar)
Valsartan (Diovan)
Angiotensin-Receptor Neprilysin Inhibitors (ARNIs)
Sacubitril/valsartan
If Channel Blocker
Ivabradine (Corlanor)
Beta Blockers
Bisoprolol (Zebeta)
Metoprolol Succinate (Toprol XL)
Carvedilol (Coreg)
Others

Aldosterone Antagonists
Spironolactone (Aldactone)
Eplerenone (Inspra)
Diuretics
Furosemide (Lasix)
Bumetanide (Bumex)
Torsemide (Demadex)
Chlorothiazide (Diuril)
Amiloride (Midamor Chlorthalidone (Hygroton)
Hydrochlorothiazide or HCTZ (Esidrix, Hydrodiuril)
Others

Anticoagulants (Blood Thinners)
Cholesterol Lowering Drugs (Statins)
Digoxin

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Blog: https://globalresearchtrends.blogspot.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Heart Failure (AHF) Therapeutics Market: Drivers, Regional Analysis, and Competitive Landscape 2026 here

News-ID: 1121092 • Views: 1213

More Releases from Coherent Market Insights

Sheet Face Masks Market - As Companies Committed for Digital Transformation, the …
Coherent Market Insights has released a new research study on the "Sheet Face Masks Market," which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Sheet Face Masks Market Report's detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Sheet Face Masks market research report
Lipid Testing Market Insights: 2022, Growing Business Demand and Upcoming Opport …
Coherent Market Insights has released a new research study on the "Lipid Testing Market," which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Lipid Testing Market Report's detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Lipid Testing market research report is an intelligence
After-sun Products Market - As Companies Committed for Digital Transformation, t …
Coherent Market Insights has released a new research study on the "After-sun Products Market," which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global After-sun Products Market Report's detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The After-sun Products market research report is an intelligence
Online Retail Market Will Generate Massive Growth 2022-2028 |Amazon Inc., Alibab …
Coherent Market Insights has released a new research study on the "Online Retail Market," which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Online Retail Market Report's detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Online Retail market research report is an intelligence

All 5 Releases


More Releases for AHF

Development of Global Anhydrous Hydrogen Fluoride (AHF) Market | Insights & Key …
Researchmoz added Most up-to-date research on "Global Anhydrous Hydrogen Fluoride (AHF) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024" to its huge collection of research reports. Anhydrous hydrogen fluoride (AHF) is a colorless liquid corrosive, and has a sharp and penetrating odor. AHF vapor reacts with the moisture in the atmosphere to form a visible dense cloud. Interpret a Competitive Outlook Analysis with FREE Sample Report: https://www.researchmoz.us/enquiry.php?type=S&repid=2122293 Scope of the
Anhydrous Hydrogen Fluoride (AHF) Global Market 2018 Growth Analysis Report & Fo …
UpMarketResearch published an Exclusive report on “Anhydrous Hydrogen Fluoride (AHF)” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains Anhydrous Hydrogen Fluoride (AHF) pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Anhydrous Hydrogen Fluoride (AHF) Market, especially in North America, Europe and Asia-Pacific, South America,
Global Anhydrous Hydrogen Fluoride (AHF) Market Research Analysis and Demand
Qyresearchreports include new market research report Global Anhydrous Hydrogen Fluoride (AHF) Market Professional Survey Report 2017 to its huge collection of research reports. QYResearchReports.com has added a new report covering the global Anhydrous Hydrogen Fluoride market to its vast database. The research report studies the global Anhydrous Hydrogen Fluoride market to analyze the factors impacting it. The report has been divided into several chapters that discuss the global Anhydrous Hydrogen Fluoride
Global Anhydrous Hydrogen Fluoride (AHF) market 2017 - Honeywell, Solvay, Ineos, …
Apex Market Reports, recently published a detailed market research study focused on the "Anhydrous Hydrogen Fluoride (AHF) Market" across the global, regional and country level. The report provides 360° analysis of "Anhydrous Hydrogen Fluoride (AHF) Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Anhydrous Hydrogen Fluoride (AHF) industry, and estimates the
Global Anhydrous Hydrogen Fluoride (AHF) (100% HF) Market Share by Players, Regi …
"The Report Global Anhydrous Hydrogen Fluoride (AHF) (100% HF) Detailed Analysis Report 2017-2022 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Anhydrous Hydrogen Fluoride
Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast 20 …
Acute heart failure (AHF) Wiseguyreports.Com Adds “Acute heart failure (AHF) Market -Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Description: The Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2022 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK)